Would young children who have Down Syndrome but no other comorbidities be classified as a child with a medical comorbidity? Or are they considered to have a severe neurological impairment? (My thought would be no, but I’m biased as all get out on the subject.)
I know it’s a terribly specific question, but here in the U.S., the risk of Covid to Down Syndrome children has basically been answered with, “We don’t know, but probably, so never leave your house and definitely mask your two-year-old.”
The US had approved a third shot for the 5-11 demographic a couple months back. Since that cohort has the lowest inherent risk, is there a rationale based upon outcome that justifies a third dose for children without comorbidity? I acknowledge the short term increases to antibodies and the increased diversity of T cells with a third dose, but do those elements changes the outcome related to severity, duration, MIS-C, PASC, etc?
Would young children who have Down Syndrome but no other comorbidities be classified as a child with a medical comorbidity? Or are they considered to have a severe neurological impairment? (My thought would be no, but I’m biased as all get out on the subject.)
I know it’s a terribly specific question, but here in the U.S., the risk of Covid to Down Syndrome children has basically been answered with, “We don’t know, but probably, so never leave your house and definitely mask your two-year-old.”
The US had approved a third shot for the 5-11 demographic a couple months back. Since that cohort has the lowest inherent risk, is there a rationale based upon outcome that justifies a third dose for children without comorbidity? I acknowledge the short term increases to antibodies and the increased diversity of T cells with a third dose, but do those elements changes the outcome related to severity, duration, MIS-C, PASC, etc?
Good article, thank you! Are there any prophylactics you would recommend in lieu of vaccination for high-risk children?